Adibendan

DB20623ExperimentalSmall molecule

Adibendan is a small molecule drug. The usage of the INN stem '-dan' in the name indicates that Adibendan is a cardiac stimulant, pimobendan derivative. Adibendan has a monoisotopic molecular...

Mechanism: Pharmacologically active on Phosphodiesterase 3
Curator reviewed
Formula / weight: C₁₆H₁₄N₄O · 278.315 g/mol (avg)

Resolves to

Compound

UNIIE87N3L27KXCAS100510-33-6ChEMBLCHEMBL25931ChEBI748047PubChem65867

Structure

InChIKeyTVLQBBHUNDMTEC-UHFFFAOYSA-NSMILESCC1(C)C(=O)NC2=C1C=C1NC(=NC1=C2)C1=CC=NC=C1

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which companies are running trials of Adibendan, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account